Effect of Sotagliflozin on Kidney Function and Cardio‐Kidney‐Metabolic Parameters Across Baseline eGFR Subgroups in Patients With Type 2 Diabetes and Stage 4 CKD
Vikas S. Sridhar, Luxcia Kugathasan, Manon Girard, Michael J. Davies, David Z. I. Cherney. Effect of Sotagliflozin on Kidney Function and Cardio‐Kidney‐Metabolic Parameters Across Baseline eGFR Subgroups in Patients With Type 2 Diabetes and Stage 4 CKD. // Diabetes, Obesity and Metabolism. – 2026. – DOI: 10.1111/dom.71256. – URL: https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.71256?af=R
Vikas S. Sridhar, Luxcia Kugathasan, Manon Girard, Michael J. Davies, & David Z. I. Cherney (2026). Effect of Sotagliflozin on Kidney Function and Cardio‐Kidney‐Metabolic Parameters Across Baseline eGFR Subgroups in Patients With Type 2 Diabetes and Stage 4 CKD. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71256
Vikas S. Sridhar, et al. “Effect of Sotagliflozin on Kidney Function and Cardio‐Kidney‐Metabolic Parameters Across Baseline eGFR Subgroups in Patients With Type 2 Diabetes and Stage 4 CKD.” Diabetes, Obesity and Metabolism, 2026. doi:10.1111/dom.71256.
@article{Sridhar2026,
title = {Effect of Sotagliflozin on Kidney Function and Cardio‐Kidney‐Metabolic Parameters Across Baseline eGFR Subgroups in Patients With Type 2 Diabetes and Stage 4 CKD},
author = {Sridhar, Vikas S. and Kugathasan, Luxcia and Girard, Manon and Davies, Michael J. and Cherney, David Z. I.},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.71256},
url = {https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.71256?af=R}
}